Global Nuclear Medicine Market is expected to reach US$ 12.17 Bn by 2028 from US$ 6.19 Bn in 2019 at a CAGR of 9.0 % during the forecast period.

The report includes an analysis of the impact of COVID-19 lockdown on the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region.
Nuclear Medicine Definition:

Nuclear medicine is the branch of medicine that deals with the use of radioactive substances in research, diagnosis, and treatment.
Global Nuclear Medicine Market Dynamics:

Increasing incidences of cancer and cardiovascular disease are driving the global market. Huge investment in the applications of radiopharmaceuticals led to give lucrative opportunities for the global nuclear medicine market. The growing need for accurate diagnostic methods triggers the nuclear medicine market.

Recent significant advances in monoclonal antibody techniques for pretargeting make it very likely that radiopharmaceuticals will become an important part of therapy for various cancers. Today the field of nuclear medicine is going through an extremely interesting and exciting phase and is poised for greater growth and development in the coming years.

Medical professionals and biomedical researchers from all over the world come together and engaged in clinical research & development aspects of radionuclide therapy. The seminar addressed by regulatory bodies and national organizations tries to deliver the current trends in therapeutic nuclear medicine, evaluated established procedures, and assessed the reemergence of certain old procedures.

The grounds of molecular biology, immunology, and genetics have produced numerous significant improvements that press on the perceptive of the introduction & development of nuclear medicines. A variety of nuclear medicine is being developed and some are under clinical investigations which have different targeting mechanisms, routes, and forms of administration.
Global Nuclear Medicine Market Segment Analysis:

The report groups the Global Nuclear Medicine Market in different segments By Type, Application, and Region to forecast the revenues and analyze the market share of each segment over the forecast period.

Global Nuclear Medicine Market

To know about the Research Methodology :- Request Free Sample Report

Based on Type, the Global Nuclear Medicine Market is segmented into Diagnostics, Therapeutics. The Therapeutic segment is sub-segmented into Beta emitters, Alpha Emitters, and Brachytherapy.

The alpha emitters segment was dominant in 2019 and is expected to command a market share of xx% by 2026. Cancer therapy with alpha-particle emitters is surely one of the most demanding multidisciplinary endeavors. Alpha emitters achieve the desired biodistribution and associated dose distribution necessary for successful nuclear medicine with acceptable acute and long-term toxicities.

An increase in awareness among cancer patients about alpha emitter therapy is the driving factor of the global market. The large scope of clinical development in radiotherapy is generating lucrative opportunities for the global market. High research & development expenditure and continuous efforts to find out alpha emitters applications in medicinal therapeutics are propelled the growth of the global market.
Global Nuclear Medicine Market Regional Insights:

Global Nuclear Medicine Market 1
North America is expected to command the largest market share of xx% by 2026

The rapid adoption of efficient nuclear imaging technologies coupled with the increasing usage of technologically advanced and efficient therapeutic radiopharmaceuticals across the region will lead to market growth in the region. The increasing prevalence of various cancers and other chronic disorders along with new product launches in newer applications are expected to fuel the growth of the market in North America during the forecast period.

The objective of the report is to present a comprehensive analysis of the Global Nuclear Medicine Market to the stakeholders in the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.

The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding the Global Nuclear Medicine Market dynamics, structure by analyzing the market segments and projects Global Nuclear Medicine Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Nuclear Medicine Market make the report investor’s guide.
Scope of the Global Nuclear Medicine Market Report: Inquire before buying

Global Nuclear Medicine Market 2
Global Nuclear Medicine Market Key Players

• Cardinal Health
• GE Healthcare
• Curium
• Lantheus Medical Imaging
• Bayer AG
• Bracco Imaging
• Eczacýbaþý-Monrol Nuclear Products
• Nordion
• Advanced Accelerator Applications
• NTP Radioisotopes
• JSC Isotope
• NorthStar Medical Radioisotopes
• Eckert & Ziegler
• Jubilant DraxImage
• PharmaLogic
• Institute of Isotopes Co. Ltd.
• Sinotau Pharmaceuticals
• Isotopia Molecular Imaging Limited
• SHINE Medical Technologies
• Global Medical Solutions